Maze Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/14/2026 | 5.03 M | $150.18 M | 10.20% | 8.53% |
| TRV GP IV, LLC | 08/10/2026 | 4.47 M | $133.50 M | 0.00% | 7.58% |
| ARCH VENTURE MANAGEMENT, LLC | 08/14/2026 | 4.12 M | $122.98 M | 0.00% | 6.98% |
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 3.73 M | $111.38 M | 7.33% | 6.33% |
| BLACKROCK, INC. | 08/07/2026 | 3.50 M | $104.52 M | 36.27% | 5.94% |
| JUPITER TOPCO LLC | 08/14/2026 | 3.41 M | $101.76 M | 100.00% | 5.78% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2026 | 2.60 M | $77.69 M | 100.00% | 4.41% |
| LOGOS GLOBAL MANAGEMENT LP | 08/14/2026 | 1.94 M | $57.74 M | 56.68% | 3.28% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 1.78 M | $53.06 M | 23.86% | 3.01% |
| AH CAPITAL MANAGEMENT, L.L.C. | 08/14/2026 | 1.70 M | $50.79 M | 0.00% | 2.89% |
| VR ADVISER, LLC | 08/14/2026 | 1.60 M | $47.80 M | 0.00% | 2.72% |
| ALPHABET INC. | 08/07/2026 | 1.39 M | $41.44 M | 0.00% | 2.35% |
| BRAIDWELL LP | 08/14/2026 | 1.14 M | $34.02 M | 100.00% | 1.93% |
| FARALLON CAPITAL MANAGEMENT LLC | 08/14/2026 | 1.11 M | $33.06 M | 197.00% | 1.88% |
| FMR LLC | 08/13/2026 | 1.06 M | $31.54 M | 22.30% | 1.79% |
| GENERAL CATALYST GROUP MANAGEMENT, LLC | 08/17/2026 | 1.04 M | $30.91 M | 0.00% | 1.76% |
| STATE STREET CORP | 09/22/2026 | 997.53 K | $29.77 M | 56.67% | 1.69% |
| JPMORGAN CHASE & CO | 08/12/2026 | 964.01 K | $28.00 M | 1,549.40% | 1.63% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/14/2026 | 954.89 K | $28.49 M | 50.10% | 1.62% |
| TRV GP V, LLC | 08/10/2026 | 950.80 K | $28.37 M | 0.00% | 1.61% |
| MARSHALL WACE, LLP | 08/13/2026 | 914.57 K | $27.29 M | 194.42% | 1.55% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 858.05 K | $25.61 M | 43.02% | 1.45% |
| CITADEL ADVISORS LLC | 09/02/2026 | 852.68 K | $25.44 M | 9.92% | 1.45% |
| CASDIN CAPITAL, LLC | 08/14/2026 | 843.86 K | $25.18 M | 11.20% | 1.43% |
| ARROWMARK COLORADO HOLDINGS LLC | 08/13/2026 | 767.38 K | $22.90 M | 0.00% | 1.30% |
| WOODLINE PARTNERS LP | 08/14/2026 | 736.22 K | $21.97 M | 13.22% | 1.25% |
| BESSEMER GROUP INC | 08/12/2026 | 481.79 K | $14.38 M | 0.00% | 0.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 08/14/2026 | 417.56 K | $12.46 M | 83.67% | 0.71% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 393.11 K | $11.73 M | 101.03% | 0.67% |
| ABRDN PLC | 07/31/2026 | 383.77 K | $11.45 M | 69.64% | 0.65% |
| IKARIAN CAPITAL, LLC | 08/14/2026 | 379.00 K | $11.31 M | 0.00% | 0.64% |
| HHLR ADVISORS, LTD. | 08/14/2026 | 366.03 K | $10.92 M | 0.00% | 0.62% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 339.28 K | $10.12 M | 577.27% | 0.58% |
| SQUADRON CAPITAL MANAGEMENT LLC | 08/14/2026 | 335.00 K | $10.00 M | 30.10% | 0.57% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 321.23 K | $9.59 M | 64.66% | 0.54% |
| NORTHERN TRUST CORP | 08/13/2026 | 294.74 K | $8.80 M | 39.44% | 0.50% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 293.14 K | $8.75 M | 4.80% | 0.50% |
| CANDRIAM S.C.A. | 08/13/2026 | 273.93 K | $8.17 M | -1.52% | 0.46% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 08/14/2026 | 270.00 K | $8.06 M | 3,212.88% | 0.46% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 260.57 K | $7.78 M | 39.76% | 0.44% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 260.57 K | $7.78 M | 100.00% | 0.44% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 248.00 K | $7.40 M | -78.95% | 0.42% |
| MASS GENERAL BRIGHAM, INC | 08/07/2026 | 239.99 K | $7.16 M | 0.00% | 0.41% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 227.43 K | $6.79 M | 111.59% | 0.39% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 219.94 K | $6.56 M | 45.65% | 0.37% |
| RTW INVESTMENTS, LP | 08/14/2026 | 212.00 K | $6.33 M | 100.00% | 0.36% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 08/13/2026 | 199.87 K | $5.80 M | 437.56% | 0.34% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 192.95 K | $5.76 M | 1,117.75% | 0.33% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 188.86 K | $5.64 M | -33.61% | 0.32% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/14/2026 | 183.26 K | $5.47 M | 100.00% | 0.31% |
Maze Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 210 institutional investors and hedge funds held shares of Maze Therapeutics Inc.. The most heavily invested institutionals were:
Frazier Life Sciences Management, L.P.: 5.03 M
TRV GP IV, LLC: 4.47 M
ARCH Venture Management, LLC: 4.12 M
Deep Track Capital, LP: 3.73 M
BlackRock, Inc.: 3.5 M
Jupiter Topco LLC: 3.41 M
99.66% of Maze Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 63.40 M shares in the last 24 months. This purchase volume represents approximately $2.86 B in transactions.